Results 121 to 130 of about 451,856 (267)

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, Volume 159, Issue 7, Page 1735-1749, 1 October 2026.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source

Myasthenia Gravis and Thymoma

Muscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li   +5 more
wiley   +1 more source

THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS. THE IMPACT OF INDWELLING PLEURAL CATHETER VERSUS PLEURODESIS ON PATIENT-REPORTED OUTCOMES, NEED FOR RE-INTERVENTION, COMPLICATIONS, AND LENGTH OF STAY.

, 2021
This is a systematic review and meta-analysis of randomized controlled trials and cohort studies comparing chemical pleurodesis and indwelling pleural catheters for the management of malignant pleural effusions.
Liu, Richard Yichao
core  

Diagnostic Value of Sialic Acid in Pleural Effusion

Chinese Journal of Lung Cancer, 2010
The present study was conducted in 30 patients of malignant pleural effusion and 30 patients of non malignant pleural effusion. Pleural fluid and blood samples were taken at the time of admission, before starting any treatment.
S KHARB, S TANDON, A BANSAL
doaj  

Association of Pleural Fluid Glucose, Pleural Fluid CYFRA 21-1, and Radiographic Pleural Effusion Size with Recurrent Malignant Pleural Effusion

Background: Recurrent malignant pleural effusion (MPE) remains a significant clinical problem that often necessitates repeated interventions and negatively affects patients' quality of life.
Nanik Setijowatirandi Putra Pratomo, Ngakan Putu Parsama Putra, Fibrianti Ratnasari, Fitri Indah Sari   +3 more
core   +1 more source

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009–2019: A Real‐World Study From the UK's Haematological Malignancy Research Network

International Journal of Cancer, Volume 159, Issue 6, Page 1411-1419, 15 September 2026.
Although tyrosine kinase inhibitors (TKIs) improve chronic myeloid leukemia (CML) outcome, long‐term effects remain unclear, particularly in real‐world settings. Here, the authors examined morbidity and mortality in CML patients treated with TKIs between 2009 and 2019 in the United Kingdom.
Eleanor Kane, Alexandra Smith, Debra Howell, Catherine Cargo, Kate Rothwell, Simone Green, Russell Patmore, Eve Roman   +7 more
wiley   +1 more source

Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma

Pediatric Blood &Cancer, Volume 73, Issue 9, September 2026.
ABSTRACT Background While the presence of metastases in neuroblastoma (NB) is a well‐established prognostic factor, the clinical significance of dissemination patterns and tumour burden and their impact on response and survival remains poorly understood.
Mariona Morell‐Daniel, Santiago Pérez‐Hoyos, Aroa Soriano, Ana Coma, Amalia Varo, Raquel Hladun, Gabriela Guillén, Soraya Mico, Marta Garrido, Lourdes Rubio, Alba Rubio‐San‐Simón, Ana Minguez, Ricardo López‐Almaraz, Laura Illade, Miguel F. Segura, Lucas Moreno   +15 more
wiley   +1 more source

A novel approach in the identification of microRNAs in malignant pleural effusion for lung cancer diagnosis

Oncology Reviews
IntroductionPleural effusion, an atypical accumulation of fluid in the pleural space, has been identified as a potential indicator of several diseases, including lung cancer.
Jesús Valencia-Cervantes, Jesús Valencia-Cervantes, Gustavo Ramirez-Martínez, Margarita Isabel Palacios-Arreola, Alejandra Loaeza-Román, Martha Patricia Sierra-Vargas   +5 more
doaj   +1 more source

Medical Thoracoscopy in the Management of Malignant Pleural Effusion

, 2013
Malignant pleural effusion is one of the most common problems that chest physicians face in their everyday practice. The diagnosis of malignant pleural effusion requires either a histological or cytological demonstration of malignant cells in the pleural
YILDIRIM, HÜSEYİN
core   +1 more source

Clinical Phenotypes, Treatment, and Outcomes of Rheumatic Immune–Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors: A Rheumatologists‐Referred Multicenter German Registry Cohort

ACR Open Rheumatology, Volume 8, Issue 9, September 2026.
Objective Immune checkpoint inhibitors (ICIs) induce a broad range of immune‐related adverse events (irAEs), including rheumatic manifestations. Evidence from dedicated rheumatology cohorts on the clinical spectrum, severity, treatment, and outcomes of rheumatic irAEs (rh‐irAEs) remains limited.
Didzis Gailis, Fabian T.H. Ullrich, Sophia Dombret, Marc Schmalzing, Rebecca Hasseli‐Fräbel, Torsten Witte, Thea Thiele, Uta Kiltz, Mara Oleszowsky, Marcel Müller, Karolina Gente, Christof Specker, Matthias B. Thaler, Alla Skapenko, Hendrik Schulze‐Koops   +14 more
wiley   +1 more source